Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Awards $42.3M in Grand Opportunities Grants

NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences announced yesterday that it has awarded $42.3 million in Grand Opportunities grants to 14 research teams, most of which will use their awards to develop 'omics technologies.

The grants are being funded through the American Recovery and Reinvestment Act, and they support projects at more than 20 research institutions and organizations in 13 states.

The Grand Opportunities program was developed by the National Institutes of Health to stimulate biomedical research projects "that promise to have a significant impact on a field of biomedical science over two years," NIGMS Director Jeremy Berg said in a statement.

Project titles, funding amounts, principal investigators, and institutions receiving GO grants from NIGMS include:

• VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment; $1.4 million. PIs: Daniel Masys and Dan Roden, Vanderbilt University Medical Center in Nashville, Tenn.

• Gene Expression and Regulatory Networks in Human Leukocytes; $7.3 million. PIs: Christophe Benoist and Diane Mathis, Harvard Medical School, Boston.

• ImageJ as an Extensible Image-Processing Framework; $1.8 million. PI: Kevin Eliceiri, University of Wisconsin-Madison.

• Metabolomics Network for Drug Response Phenotype; $4.5 million. PIs: Rima Kaddurah-Daouk, Duke University Medical Center, Durham, NC.

• The Arabidopsis Transcription Factor ORFeome and Downstream Genomic Application; $2 million. PIs: Steve Kay, University of California, San Diego, and Joseph Ecker, Salk Institute for Biological Studies, La Jolla, Calif.

• A Multi-disciplinary Approach to Elucidating Gene Function in a Model Gram-Positive Bacterium; $2 million. PI: David Rudner, Harvard Medical School.

• SciBay: A New Methodology for Scientific Collaboration and Gene Function Determination; $4 million. PIs: Martin Steffen and Simon Kasif, Boston University School of Medicine, and Richard Roberts, New England BioLabs, Ipswich, Mass.

• Innovative Supercomputing for Breakthrough Molecular Dynamics; $2.7 million. PI: Joel Stiles, Carnegie Mellon University, Pittsburgh.

A full list of grant recipients and project descriptions can be found here.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.